Shopping Cart
- Remove All
Your shopping cart is currently empty
Tolazoline hydrochloride (NSC35110 (hydrochloride)) is a non-selective competitive α-adrenergic receptor antagonist used in treatment of persistent pulmonary hypertension of the newborn.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 g | $30 | In Stock | |
| 5 g | $55 | In Stock | |
| 10 g | $77 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $30 | In Stock |
| Description | Tolazoline hydrochloride (NSC35110 (hydrochloride)) is a non-selective competitive α-adrenergic receptor antagonist used in treatment of persistent pulmonary hypertension of the newborn. |
| In vivo | In cases of persistent pulmonary hypertension of the newborn (PPHN), Tolazoline acts as a pulmonary vasodilator, effectively reducing pulmonary vascular resistance (PVR) and pulmonary arterial pressure. Additionally, within the human radial artery, Tolazoline blocks α-adrenergic activity, significantly counteracting vascular spasms. |
| Synonyms | Tolazoline HCl, NSC35110 (hydrochloride), Imidaline hydrochloride, Imidaline (hydrochloride), Benzidazol hydrochloride |
| Molecular Weight | 196.68 |
| Formula | C10H13ClN2 |
| Cas No. | 59-97-2 |
| Smiles | Cl.C(C1=NCCN1)c1ccccc1 |
| Relative Density. | 1.09g/cm3 |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | H2O: 36 mg/mL (183.04 mM), Sonication is recommended. DMSO: 55 mg/mL (279.64 mM), Sonication is recommended. Ethanol: 37 mg/mL (188.12 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (10.17 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
H2O/Ethanol/DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.